A NSW Government website

On

Neurology Research

Our Research Team

Associate Professor Rebekah Ahmed

Associate Professor, Brain and Mind Centre

Staff Specialist Neurologist, Royal Prince Alfred Hospital

Professor Craig Anderson

Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney

Neurologist, Royal Prince Alfred Hospital

Professor Michael Barnett
MBBS (Hons), FRACP, FRCP, PhD

Consultant Neurologist, Royal Prince Alfred Hospital

Senior Academic, University of Sydney

Director, RPA Muscular Sclerosis Clinic and Muscular Sclerosis Clinical Trials Unit, Brain and Mind Centre

Co-director, MS Research Australia Brain Bank

Prof G. Michael Halmagyi

Consultant Neurologist, Royal Prince Alfred Hospital

Professor of Neurology, University of Sydney

Professor Matthew Kiernan AM
MBBS (Hons) (USYD), PhD (UNSW), DSc (UNSW), FRACP, FAHMS

Bushell Professor of Neurology, University of Sydney, Brain and Mind Centre and Royal Prince Alfred Hospital

Co -Director, Brain and Mind Centre – Discovery and Translation

Associate Professor Armin (Mohamed) Nikpour
MBBS (Hons), FRACP, BSc (Math)

Director, Comprehensive Epilepsy Service, Royal Prince Alfred Hospital and University of Sydney

Associate Professor Miriam Welgampola
BSc Med (Hon), FRACP, PhD

Consultant Neurologist, Royal Prince Alfred Hospital

Associate Professor of Neurology, University of Sydney

Associate Professor John Worthington Director, Comprehensive Stroke Service, Royal Prince Alfred Hospital

Selected Grants

Amount awarded Grant and project details
$24,025,090 NHMRC, 2019-2024
Clinical, public health and policy interventions to combat cardiovascular diseases
Investigators: Neal B, Patel A, Anderson C,  Woodward M, Rodgers A, Perkovic V, Chalmers J, Chow C, Lindley R, Jan S
$4,016,415 MRFF, 2020-2023
TRANSCEND: TRanslating AI Networks to Support Clinical Excellence in Neuro Diseases
Investigators: Barnett MH, Wang C,  Shieh A, Calamante F, Ouyang W, Cai W, Sullivan R, Shnier R, Masters L.
£2,000,000.00  MRC (UK), 2020-2023
The third, intensive care bundle with blood pressure reduction in acute cerebral haemorrhage (INTERACT 3) trial
Investigator: Anderson CS
$3,000,000 NHMRC, 2022-2027
NHMRC Centre of Research Excellence in Enhanced Dementia Diagnosis (CREEDD). 
Investigators: Ayton S, Brodtman A, Bush A, Ayton D, Bammer R, Lim Y, Wooward M, Ahmed RM, Ahern S, Liew D.
$2,795,200 NHMRC, 2021-2026
Clinical trial to determine the effects of statins on cognition: STAREE-Mind
Investigators: Ryan J, Zoungas S, Anderson C, Law M, Chong T, Harding I, Heritier S, Naismith S, O’Sullivan M, Liew D
$2,758,598 NHMRC, 2020-2024
Extending the time window for Tenecteplase by Effective Reperfusion of peNumbrAL tissue in patients with Large Vessel Occlusion (ETERNAL)
Investigators: Parsons M, Butcher K, Campbell B, Churilov L, Davis S, Anderson CS, Moodie M, Levi C, Markus H, Coutts S
$2,706,533 MRFF, 2021-2024
Safety and Tolerability of AZD6482 in Reperfusion for Stroke (STARS)
Investigators: Jackson S, Delcourt C, Anderson C, Di Tanna GL, Schoenwaelder S, Ang T
 $2,375,779 MRFF, 2021-2023
Statin Treatment for COVID-19 to optimise Neurological Recovery (STRONGER) trial
Investigators: Anderson, CS
$2,029,361 MRFF Clinical Trials Activity Initiative, 2022-2025
Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED-MT).
Investigators: Anderson C, Song L, Chen X, Parsons M, Wang X, Butcher K, Campbell B.
$1,995,481 NHMRC, 2019-2023
Translating the evidence on dementia risk reduction to generate assessments, advice and training for health professionals, policy makers, patients and public.
Investigators: Anstey K, Peters R, Lautenschlager N, Shaw J, Anderson C, Jorm L, Kiely K, Whitmer R, Matthews F, Kivipelto M
$1,774,988 MRFF 2020 Clinician Researchers - Applied Research in Health, 2022-2025
Optimal Post rTPA-iv Monitoring in Ischaemic Stroke (OPTIMISTmain) clinical trial.
Investigators: Anderson CS.
$1,604,184 MRFF - Rare Cancers, Rare Diseases and Unmet Need (RCRDUN), 2020-2023
Evaluating the effectiveness and safety of sodium selenate as a disease modifying treatment for patients with behavioural variant Frontotemporal Dementia (bvFTD)
Investigators: Piguet O, O'Brien T, Malpas C, Velakoulis D, Brodtmann A, Kalincik T, Walterfang M, Ahmed R, Bush A, Darby D
$1,600,000 NHMRC, 2019-2023
Motor Neurone Disease: Patient centred care for a progressive neurological disease - evidence driving policy
Investigators: Kiernan MC, Wray N, Talman P, Vucic S, Mathers S, Henderson R, Bellgard M, Aoun S, Savulescu J, Rowe D
$1,401,595 NHMRC, 2020-2024
Generating new evidence & improving health systems to improve the management of stroke across the globe
Investigators: Anderson CS
$771,042 NHMRC/Partnership Project for Better Health, 2018-2023
Motor Neurone Disease: Patient centred care for a progressive neurological disease - evidence driving policy
Investigators: 
Kiernan M
$600,000 NHMRC DCRC, 2020-2024
World Class Research grant. Frontotemporal Dementia or Autism spectrum disorder
Investigators: Piguet O, Gustella A, Kumfor F, Ahmed RM
$585,270 NHMRC Practitioner Fellowships, 2019-2023
Developing new therapies for neurodegeneration and dementia
Investigators: Kiernan M.
$530,000 Fight MND Research Grant, 2022-2025
Multi-arm, Adaptive, Group sequential trial NETwork to evaluate drug efficacy in patients with MND (MAGNET).
Investigators: Kiernan MC.

Our Publications

2022

Ahnood A, Truong ND, Fleiss B, Nikpour A, Kavehei O. Novel electrode architecture for subgaleal electroencephalography: a feasibility study. Sensors & Diagnostics. 2022;1(2):245-61.
Anderson CS, Rodgers A, de Silva A, Martins SO, Klijn CJM, Senananyake B, Freed R, Billot L, Arima H, Thang NH, Wan Zaidi WAW, Kherkheulidze T, Wahab K, Fisher U, Lee T-HL, Chen C, Pontes-Neto O, Robinson TG, Wang J, Naismith S, Song L, Schreuder FH, Lindley RI, Woodward M, MacMahon S, Chalmers J for the TRIDENT Research Group. Triple therapy prevention of Recurrent Intracerebral Disease Events Trial (TRIDENT): rationale, design and progress. International Journal of Stroke 2022;17(10):1156-1162.  PMID: 34994269.  DOI:  10.1177/17474930211068671.
Anderson CS. (Editorial) Cerebrovascular Diseases 2022; 51:1–2. DOI: 10.1159/000521617.
Anderson CS. (Peer Review Report) Stroke pathway. an evidence base for commissioning. An evidence review for NHS England and NHS Improvement [version 1; peer review: 1 approved with reservations]. NIHR Open Res 2022;2:43 DOI: 10.3310/nihropenres.14373.r28721.
Barnett M, Barnett Y, Reddel S: MRI and laboratory monitoring of disease-modifying therapy efficacy and risks. Current Opinion in Neurology 2022, 35:278-285.
Bhartia K, Briest R, Goetti R, Webster R, Troedson C, Dale RC, Miteff F,  Muthusami P, Miteff C,  Worthington J, Tastula K, Ang T,  Andrews I. Pediatric large vessel occlusion stroke: poor outcomes without intervention. Presented at American Heart Association ISC 2022 February 9-11 New Orleans. Stroke, February 2022 - Volume 53, Issue Suppl_1: Abstracts From the American Stroke Association 2022 International Stroke Conference and State-of-the-Science Stroke Nursing Symposium 2022
Bhatia KD, Briest R, Goetti R, Webster R, Troedson C, Dale RC, Muthusami P, Miteff C, Miteff F, Worthington J, Tastula K, Ang T, Andrews I. Incidence and Natural History of Pediatric Large Vessel Occlusion Stroke: A Population Study. JAMA Neurol. 2022 May 1;79(5):488-497. doi: 10.1001/jamaneurol.2022.0323. PMID: 35344005; PMCID: PMC8961400.
Billot L, Song L, Hu X, Ma L, Ouyang M, Chen X, You C, Anderson CS; INTERACT3 Investigators. Statistical Analysis Plan for the INTEnsive Care Bundle with Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial: a stepped-wedge cluster randomized controlled trial. Cerebrovascular Diseases 2022 Sep 5:1-4. doi: 10.1159/000526384. [Epub ahead of print] PMID: 36063792.
Bocchetta M, Todd EG, Tse NY, Devenney EM, Tu S, Caga J, … Kiernan MC, et al. Thalamic and Cerebellar Regional Involvement across the ALS-FTD Spectrum and the Effect of C9orf72. Brain Sci. 2022;12(3).
Bukhari W, Khalilidehkordi E, Mason DF, Barnett MH, Taylor BV, Fabis-Pedrini M, Kermode AG, Subramanian S, Waters P, Broadley SA: NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand. Journal of Neurology 2022, 269:836-845.
Carnemolla S, Kumfor F, Liang CT, Foxe D, Ahmed RM, Piguet O. Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer’s Disease. Journal of Alzheimer's Disease. 2022 Jan 1(Preprint):1-6.
Carroll A, Dyck PJ, de Carvalho M, Kennerson M, Reilly MM, Kiernan MC, et al. Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis. J Neurol Neurosurg Psychiatry. 2022.
Carroll AS, Howells J, Lin CSY, Park SB, Simon N, Reilly MM, … Kiernan MC, et al. Differences in nerve excitability properties across upper limb sensory and motor axons. Clin Neurophysiol. 2022;136:138-49.
Chen X, Anderson CS. (Editorial) Revisiting the adiposity paradox for the risk of stroke subtypes JAMA Network Open 2022;5(12):e2246621. doi:10.1001/jamanetworkopen.2022.46621
Clarke L, Bukhari W, O'Gorman CM, Khalilidehkordi E, Arnett S, Woodhall M, Prain KM, Parratt JD, Barnett MH, Marriott MP: Response to treatment in NMOSD: the Australasian experience. Multiple Sclerosis and Related Disorders 2022, 58:103408.
Cornblath DR, Kiernan MC, Kimura J, Koltzenburg M, Lewis RA, Parry GJ, et al. Letter to the Editor re "Complete Foot Drop With Normal Electrodiagnostic Studies: Sunderland 'Zero' Ischemic Conduction Block of the Common Peroneal Nerve" by Peters and Colleagues. Ann Plast Surg. 2022.
Cree BA, Hartung H-P, Barnett M: New drugs for multiple sclerosis: new treatment algorithms. Current Opinion in Neurology 2022, 35:262-270.
Crilly S, Parry-Jones A, Wang X, Selley JN, Cook J, Tapia VS, Anderson CS, Allen SM, Kasher PR.  Zebrafish drug screening identifies candidate therapies for neuroprotection after spontaneous intracerebral haemorrhage. Disease Models and Mechanisms 2022;15(3) dmm049227. E-ollection.  DOI: 10.1242/dmm.049227. PMID: 35098999.
Dammers R, Beck J, Volovici V, Anderson CS, Klijn CJM. Advancing the surgical treatment of intracerebral hemorrhage: study design and research directions. World Neurosurgery 2022;161:367-375. doi: 10.1016/j.wneu.2022.01.084. PMID: 35505556.
De Oliveira HM, Silsby M, Jaiser SR, Lai HM, Pavey N, Kiernan MC, et al. Electrodiagnostic findings in facial onset sensory motor neuronopathy (FOSMN). Clin Neurophysiol. 2022.
D'Souza A, Wang C, Tu S, Soligo DJ, Kiernan MC, Barnett M, Calamante F: A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods. Journal of the Peripheral Nervous System 2022, 27:67-83.
Dunkerton S, Penninkilampi R, Beadnall H, Fulham M, Colebatch A, Jankelowitz S, Ahmed R, Thayer Z, Halmagyi M, Abadir E. Erdheim-Chester disease presenting as precipitous cognitive decline. Practical Neurology. 2022 Oct 25.
Ebker-White A, Dinh M, Paver I, Bein K, Tastula K, Gattellari M, Worthington J. Evaluating Stroke Code Activation Pathway in Emergency Departments study. Emerg Med Australas. 2022 Dec;34(6):976-983. doi: 10.1111/1742-6723.14032. Epub 2022 Jul 18. PMID: 35851729.
El-Wahsh S, Greenup D, White G, Thompson EO, Aggarwal A, Fulham MJ, Halmagyi GM. Diaschisis: a mechanism for subcortical aphasia? J Neurol. 2022 Apr;269(4):2219-2221. doi: 10.1007/s00415-021-10861-7. Epub 2021 Oct 24. PMID: 34689219.
Foxe D, Hu A, Cheung SC, Ahmed RM, Cordato NJ, Devenney E, Hwang YT, Halliday GM, Mueller N, Leyton CE, Hodges JR. Utility of the Addenbrooke’s Cognitive Examination III online calculator to differentiate the primary progressive aphasia variants. Brain Communications. 2022;4(4):fcac161.
Gallina A, Disselhorst-Klug C, Farina D, Merletti R, Besomi M, Holobar A, … Kiernan MC,  et al. Consensus for experimental design in electromyography (CEDE) project: High-density surface electromyography matrix. J Electromyogr Kinesiol. 2022;64:102656.
Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, et al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022.
Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022.
Grima N, Henden L, Fearnley LG, Rowe DB, D'Silva S, Pamphlett R, … Kiernan MC, et al. NEK1 and STMN2 short tandem repeat lengths are not associated with Australian amyotrophic lateral sclerosis risk. Neurobiol Aging. 2022;116:92-5.
Halmágyi GM, Kumar K, McGarvie LA. The visually enhanced vestibulo-ocular reflex in CANVAS. J Neurol. 2022 Jan;269(1):490-492. doi: 10.1007/s00415-021-10755-8. Epub 2021 Aug 14. PMID: 34390396.
Halmagyi GM, Parker GD, Chen L, Welgampola MS, Watson JDG, Barnett MH, Todd MJ, El-Wahsh S, Rose V, Stoodley MA, Brennan JW. Progressive loss of hearing and balance in superficial siderosis due to occult spinal dural defects. Eur Arch Otorhinolaryngol. 2023 Feb;280(2):633-641. doi: 10.1007/s00405-022-07523-3. Epub 2022 Jul 16. PMID: 35841407; PMCID: PMC9849153.
Hannigan IP, Rosengren SM, Young AS, Bradshaw AP, Calic Z, Kwok B, Alraddy B, Gibson WPR, Kong J, Flanagan S, Halmagyi GM, Watson SRD, Welgampola MS. A Portrait of Menière's Disease Using Contemporary Hearing and Balance Tests. Otol Neurotol. 2022 Apr 1;43(4):e489-e496. doi: 10.1097/MAO.0000000000003479. PMID: 35085109.
Hardy T, Aouad P, Barnett M, Blum S, Broadley S, Carroll W, Crimmins D, Griffiths D, Hodgkinson S, Lechner-Scott J: Novel real world evidence from mSGo, a digital support program for secondary Progressive multiple sclerosis patients in Australia using siponimod. Multiple Sclerosis Journal 2022, 28:895-896.
Hardy TA, Parratt J, Beadnall H, Blum S, Macdonell R, Beran RG, Shuey N, Lee A, Carroll W, Shaw C: Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data. BMJ neurology open 2022, 4.
Hawkes MA, Anderson CS, Rabinstein AA. Blood pressure variability after cerebrovascular events: a possible new therapeutic target: a narrative review. Neurology 2022;99(4):150-160.  DOI: 10.1212/WNL.0000000000200856. PMID: 35879090
Hop PJ, Zwamborn RAJ, Hannon E, Shireby GL, Nabais MF, Walker EM, … Kiernan MC,  et al. Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS. Sci Transl Med. 2022;14(633):eabj0264.
Hutchinson K, Ryder T, Coleman H, Nullwala R, Herkes G, Bleasel A, et al. Determining the role and responsibilities of the community epilepsy nurse in the management of epilepsy. Journal of Clinical Nursing. 2022.
Johnson EG, Kuiper W, Ahmed RM, Halliday GM, Burrell JR, Hodges JR, Guastella AJ, Piguet O, Kumfor F. Plasma Oxytocin Is Not Associated with Social Cognition or Behavior in Frontotemporal Dementia and Alzheimer’s Disease Syndromes. Dementia and Geriatric Cognitive Disorders. 2022;51(3):241-8.
Katzeff JS, Bright F, Phan K, Kril JJ, Ittner LM, Kassiou M, … Kiernan MC, et al. Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Brain. 2022.
Kiernan MC. Brainspotting: Adventures in Neurology. J Neurol Neurosurg Psychiatry. 2022;93(8):800-1.
Klistorner A, Klistorner S, You Y, Graham SL, Yiannikas C, Parratt J, Barnett M: Long-term effect of permanent demyelination on axonal survival in multiple sclerosis. Neurology-Neuroimmunology Neuroinflammation 2022, 9.
Klistorner S, Barnett M, Parratt J, Yannikas C, Graham S: Choroid Plexus Volume Predicts Expansion of Chronic Lesions and Associated Brain Atrophy in Multiple Sclerosis. 2022.
Klistorner S, Barnett MH, Graham SL, Wang C, Klistorner A: The expansion and severity of chronic MS lesions follows a periventricular gradient. Multiple Sclerosis Journal 2022, 28:1504-1514.
Klistorner S, Barnett MH, Klistorner A: Mechanisms of central brain atrophy in multiple sclerosis. Multiple Sclerosis Journal 2022, 28:2038-2045.
Klistorner S, Barnett MH, Parratt J, Yiannikas C, Graham SL, Klistorner A: Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy. Annals of Clinical and Translational Neurology 2022, 9:1528-1537.
Klistorner S, Barnett MH, Yiannikas C, Barton J, Parratt J, You Y, Graham SL, Klistorner A: Expansion of chronic MS lesions is associated with an increase of radial diffusivity in periplaque white matter. Multiple Sclerosis Journal 2022, 28:697-706.
Klistorner S, Van der Walt A, Barnett MH, Butzkueven H, Kolbe S, Parratt J, Yiannikas C, Klistorner A: Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritis. medRxiv 2022:2022.2008. 2023.22279105.
Kutlubaev MA, Caga J, Xu Y, Areprintseva DK, Pervushina EV, Kiernan MC. Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes. Amyotroph Lateral Scler Frontotemporal Degener. 2022:1-10.
Kwok, B., Rosengren, S., Kong, J., Birman, C., Hoskisson, E., Young, A., Argaet, E., Fratturo, L., Rivas, C., Greenberg, S., Saxby, A., Welgampola, M. (2022). Impact of Cochlear Implantation on Canal and Otolith Function. Otology & Neurotology, 43(3), 304-312.
Law LY, Barnett MH, Barnett Y, Masters L, Beadnall HN, Hardy TA, Reddel SW: Presumptive isolated neurosarcoidosis involving eloquent structures: An argument for empirical TNF-α inhibition. Journal of Neuroimmunology 2022, 372:577956.
Li T, Park SB, Battaglini E, King MT, Kiernan MC, Goldstein D, et al. Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use. Qual Life Res. 2022.
Liu D, Zhang C, Song Y, Huang H, Wang C, Barnett M, Cai W: Decompose to adapt: Cross-domain object detection via feature disentanglement. IEEE Transactions on Multimedia 2022.
Lopez JA, Houston SD, Tea F, Merheb V, Lee FX, Smith S, McDonald D, Zou A, Liyanage G, Pilli D: Validation of a flow cytometry live cell-based assay to detect myelin oligodendrocyte glycoprotein antibodies for clinical diagnostics. The journal of applied laboratory medicine 2022, 7:12-25.
Ma Y, Zhang C, Cabezas M, Song Y, Tang Z, Liu D, Cai W, Barnett M, Wang C: Multiple sclerosis lesion analysis in brain magnetic resonance images: techniques and clinical applications. IEEE Journal of Biomedical and Health Informatics 2022.
Maher C, D’Souza A, Barnett M, Kavehei O, Wang C, Nikpour A. Structure-function coupling reveals seizure onset connectivity patterns. Applied Sciences. 2022;12(20):10487.
Maher C, D’Souza A, Zeng R, Barnett M, Kavehei O, Nikpour A, et al. White matter alterations in focal to bilateral tonic-clonic seizures. Frontiers in Neurology. 2022;13:972590-.
Maher C, D’Souza A, Zeng R, Barnett M, Kavehei O, Nikpour A, Wang C: White matter alterations in focal to bilateral tonic-clonic seizures. Frontiers in Neurology 2022, 13:972590-972590.
Makowiecki K, Stevens N, Cullen CL, Zarghami A, Nguyen PT, Johnson L, Rodger J, Hinder MR, Barnett M, Young KM: Safety of low-intensity repetitive transcranial magneTic brAin stimUlation foR people living with mUltiple Sclerosis (TAURUS): study protocol for a randomised controlled trial. Trials 2022, 23:1-18.
Mazumder S, Kiernan MC, Halliday GM, Timmins HC, Mahoney CJ. The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review. Neuropathol Appl Neurobiol. 2022:e12845.
Merlo D, Kalincik T, Zhu C, Gresle M, Lechner-Scott J, Kilpatrick T, Barnett M, Taylor B, Buzzard K, Darby D: Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive tests. Multiple sclerosis and related disorders 2022, 58:103393.
Minhas JS, Moullaali TJ, Rinkel GJE, Anderson CS. Blood pressure management after intracerebral and subarachnoid hemorrhage: the knowns and known unknowns. Stroke 2022;53(4):1065-1073.    doi: 10.1161/STROKEAHA.121.036139. Epub 2022 Mar 8. PMID: 35255708.
Mizrahi D, Goldstein D, Kiernan MC, Robinson L, Pitiyarachchi O, McCullough S, et al. Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy. Support Care Cancer. 2022.
Mullen MT, Anderson CS. Review of long-term blood pressure control after intracerebral hemorrhage: challenges and opportunities. Stroke 2022;53(7):2142-2151. doi: 10.1161/STROKEAHA.121.036885. Epub 2022 Jun 3. PMID: 35657328.
Nham B, Reid N, Bein K, Bradshaw AP, McGarvie LA, Argaet EC, Young AS, Watson SR, Halmagyi GM, Black DA, Welgampola MS. Capturing vertigo in the emergency room: three tools to double the rate of diagnosis. J Neurol. 2022 Jan;269(1):294-306. doi: 10.1007/s00415-021-10627-1. Epub 2021 Aug 16. PMID: 34398269.
Noto YI, Kiernan MC. Hyperexcitability and ALS. J Neurol Neurosurg Psychiatry. 2022.
O’Brien TJ, Berkovic SF, French JA, Messenheimer JA, Sebree TB, Bonn-Miller MO, et al. Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial. JAMA Network Open. 2022;5(7):e2220189-e.
Ouchida S, Nikpour A, Fairbrother G. A Prospective Randomized Controlled Trial: Alternative Approach to EEG Application to Reduce Electrode-induced Skin Injury among Ambulatory EEG Patients. The Neurodiagnostic Journal. 2022;62(1):37-51.
Ouchida S, Nikpour A, Senturias M, Pears TE, Fairbrother G. Implementation of a New Clinical Testing Tool to Assess Patients During Ictal and Postictal Periods. Journal of Neuroscience Nursing. 2022;54(3):124-9.
Ouyang M, Anderson CS, Song L, Malavera A, Jan S, Cheng G, Chu H, Hu X, Ma L, Chen X, You C, Liu H. Process evaluation of an implementation trial: design, rationale, and early lessons learnt from an international cluster clinical trial in intracerebral hemorrhage. Front Med (Lausanne) 2022;9:813749. DOI:10.3389/fmed.2022.813749. PMID: 35783649; PMCID: PMC9240283 
Palmer JR, Wang C, Kong D, Cespedes M, Pye J, Hickie IB, Barnett M, Naismith SL: Rest-activity rhythms and tract specific white matter lesions in older adults at risk for cognitive decline. Molecular Psychiatry 2022:1-7.
Park SB, Li T, Kiernan MC, Garg N, Wilson I, White R, et al. Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of Australia. Muscle Nerve. 2022;66(5):576-82.
Peters R, Xu Y, Fitzgerald O, Linn Aung H, Beckett N, Bulpitt C, Chalmers J, Forette F, Gong J, Harris K, Humburg P, Matthews FE, Staessen JA, Thijs L, Tzourio J, Warwick J, Woodward M, Anderson CS, for the Dementia rIsk REduCTion (DIRECT) collaboration. Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. European Heart Journal 2022;43(48):4980-4990 ehac584.  PMID: 36282295   DOI:  10.1093/eurheartj/ehac584.
Piguet O, Ahmed RM, Kumfor F. The Role of Oxytocin in Social Circuits and Social Behavior in Dementia. In Oxytocin 2022 (pp. 67-80). Humana, New York, NY.
Pillay A, Yeola A, Houston S, Maltby V, Fabis-Pedrini M, Le-Kavanagh L, Merheb V, Lee FX, Walters S, Van Roijen M: Spike antibody seroconversion and breadth following SARS-CoV-2 vaccination in Australian people with multiple sclerosis. Multiple Sclerosis Journal 2022:520-521.
Pogson JM, Halmagyi GM. Hearing but not understanding: word deafness from a brainstem lesion. Lancet. 2022 Feb 19;399(10326):756. doi: 10.1016/S0140-6736(22)00191-X. PMID: 35183296.
Pogson JM, Taylor RL, Bradshaw AP, McGarvie L, D'Souza M, Flanagan S, Kong J, Biggs N, Shivalingam B, Greenberg S, Croxson G, Halmagyi GM, Welgampola MS. The human vestibulo-ocular reflex and compensatory saccades in schwannoma patients before and after vestibular nerve section. Clin Neurophysiol. 2022 Jun;138:197-213. doi: 10.1016/j.clinph.2022.02.014. Epub 2022 Mar 1. PMID: 35370080.
Ramanan S, El-Omar H, Roquet D, Ahmed RM, Hodges JR, Piguet O, Lambon Ralph MA, Irish M. Mapping behavioural, cognitive and affective transdiagnostic dimensions in frontotemporal dementia. Brain Communications. 2023;5(1):fcac344.
Räuber S, Korsen M, Huntemann N, Rolfes L, Müntefering T, Dobelmann V, Hermann AM, Kölsche T, von Wnuck Lipinski K, Schroeter CB: Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab. Journal of Neurology, Neurosurgery & Psychiatry 2022, 93:978-985.
Räuber S, Willison A, Korsen M, Kölsche T, Golombeck KS, Plaack B, Schüller J, Huntemann N, Rolfes L, Schroeter CB: Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab. Frontiers in Immunology 2022, 13.
Roos I, Malpas C, Leray E, Casey R, Horakova D, Havrdova EK, Debouverie M, Patti F, De Seze J, Izquierdo G: Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis. Neurology 2022, 99:e1926-e1944.
Rosengren, S., Young, A., Taylor, R., Welgampola, M. (2022). Vestibular function testing in the 21st century: video head impulse test, vestibular evoked myogenic potential, video nystagmography; which tests will provide answers? Current Opinion In Neurology, 35(1), 64-74.
Ryan A, Malavera A, Delcourt C, Anderson CS. Trial of Advanced CT Imaging and Combined Education Support for Drip and Ship: evaluating the effectiveness of an ‘implementation intervention’ in providing better patient access to reperfusion therapies: protocol for a non-randomised controlled stepped wedge cluster trial in acute stroke. BMJ Open 2022 Feb 11;12(2):e055461. doi: 10.1136/bmjopen-2021-055461. PMID: 35149571.
Sesel A-L, Sharpe L, Beadnall HN, Barnett MH, Szabo M, Naismith SL: A randomized controlled trial of a web-based mindfulness programme for people with MS with and without a history of recurrent depression. Multiple Sclerosis Journal 2022, 28:1392-1401.
Shaban S, Huasen B, Haridas A, Killingsworth M, Worthington J, Jabbour P, Bhaskar SMM. Digital subtraction angiography in cerebrovascular disease: current practice and perspectives on diagnosis, acute treatment and prognosis. Acta Neurol Belg. 2022 Jun;122(3):763-780. doi: 10.1007/s13760-021-01805-z. Epub 2021 Sep 22. PMID: 34553337.
Sharmin S, Bovis F, Malpas C, Horakova D, Havrdova EK, Izquierdo G, Eichau S, Trojano M, Prat A, Girard M: Confirmed disability progression as a marker of permanent disability in multiple sclerosis. European journal of neurology 2022, 29:2321-2334.
Sharmin S, Roos I, Simpson-Yap S, Malpas C, Sanchez MM, Ozakbas S, Horakova D, Havrdova E, Patti F, Alroughani R: The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Multiple Sclerosis Journal 2022, 28:967-970.
Shemesh AA, Kocoglu K, Akdal G, Ala RT, Halmagyi GM, Zee DS, Otero-Millan J. Modeling the effect of gravity on periodic alternating nystagmus. J Neurol Sci. 2022 Nov 15;442:120407. doi: 10.1016/j.jns.2022.120407. Epub 2022 Sep 5. PMID: 36115220.
Shibuya K, Otani R, Suzuki YI, Kuwabara S, Kiernan MC. Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets. Pharmaceuticals (Basel). 2022;15(4).
Si L, Chen X, Ouyang M, Wang X, Chen G, Cao YJ, Wu G, Zhang J, Zhang J, Liu Y, Zhang S, Song L, Delcourt C, Arima H, Wang L, Lung T, Chen M, Anderson CS, Jan S; ENCHANTED Investigators. Cost-effectiveness of low-dose compared to standard-dose alteplase for acute ischemic stroke in China: a within-trial economic evaluation of the ENCHANTED Study. Cerebrovascular Diseases 2022 Aug 31:1-8. doi: 10.1159/000525869. [Epub ahead of print] PMID: 36044836.
Song L, Yang P, Zhang YW, Zhang X, Chen X, Li Y, Shen H, Zhang L, Li Z, Zhang Y, Xing P, Zhang P, Zhou Y, Ren X, Billot L, Wang X, Parsons M, Butcher K, Campbell B, Robinson T, Goyal M, Dippel D, Roos Y, Majoie CBLM, Liu JM, Anderson CS. The second randomized controlled ENhanced Control of Hypertension ANd Thrombectomy strokE stuDy (ENCHANTED2): protocol and progress. International Journal of Stroke. 2022 Aug 4:17474930221120345. doi: 10.1177/17474930221120345. [Epub ahead of print] PMID: 35924814.
Strikwerda-Brown C, Ahmed RM, Piguet O, Irish M. Try to see it my way–Examining the relationship between visual perspective taking and theory of mind in frontotemporal dementia. Brain and Cognition. 2022 Mar 1;157:105835.
Tang Z, Wang X, Cabezas M, D’Souza A, Calamante F, Liu D, Barnett M, Wang C, Cai W: Diffusion MRI Fibre Orientation Distribution Inpainting. In Computational Diffusion MRI: 13th International Workshop, CDMRI 2022, Held in Conjunction with MICCAI 2022, Singapore, Singapore, September 22, 2022, Proceedings: Springer Nature Switzerland Cham: 2022:65-76.
Tang Z, Wang X, Zhu L, Cabezas M, Liu D, Barnett M, Cai W, Wang C: TW-BAG: Tensor-wise Brain-aware Gate Network for Inpainting Disrupted Diffusion Tensor Imaging. In 2022 International Conference on Digital Image Computing: Techniques and Applications (DICTA): IEEE: 2022:1-8.
Timmins HC, Li T, Goldstein D, Trinh T, Mizrahi D, Harrison M, … Kiernan MC, et al. The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors. J Cancer Surviv. 2022;16(2):223-32.
Triplett JD, Qiu J, O'Brien B, Gopinath S, Trewin B, Spring PJ, Shaffi M, Ip J, Chan F, Chen L: Diagnosis, differential diagnosis and misdiagnosis of Susac syndrome. European journal of neurology 2022, 29:1771-1781.
Tse NY, Tu S, Chen Y, Caga J, Dobson-Stone C, Kwok JB, Halliday GM, Ahmed RM, Hodges JR, Piguet O, Kiernan MC. Schizotypal traits across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum: pathomechanistic insights. Journal of Neurology. 2022 Mar 13:1-2.
Tse, N. Y., Bocchetta, M., Todd, E. G., Devenney, E. M., Tu, S., Caga, J., ... & Ahmed, R. M.  Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.  NeuroImage: Clinical,. 2023; 37, 103281.
Tunnage B, Woodhouse LJ, Dixon M, Anderson CS, Ankolekar S, Appleton J, Cala L, England T, Krishnan K, Havard D, Mair G, Muir K, Phillips S, Potter J, Price C, Randall M, Robinson TG, Roffe C, Sandset E, Siriwardena N, Scutt P, Wardlaw JM, Sprigg N, Bath PM; RIGHT-2 Investigators. Pre-hospital transdermal glyceryl trinitrate in patients with stroke mimics: data from the RIGHT-2 randomised-controlled ambulance trial. BMC Emergency Medicine 2022;22(1):2. doi: 10.1186/s12873-021-00560-x. PMID: 35012462; PMCID: PMC8744321.
Venturelli PM, Gonzalez F, Urrutia F, Mazzon E, Navia V, Brunser A, Lavados P, Olavarria V, Almeida J, Guerrero R, Rojo A, Gigoux JP, Vallejos J, Conejan N, Esparza T, Escobar A, Soto A, Pontes Neto O, Arauz A, Abanto C, Carcel C, Zafra-Tanaka JH, Liu H, Song L, Miranda JJ, Anderson CS. Stroke academic research in Latin America. Salud Pública de México 2022;64:S40-S45. DOI: 10.21149/12803.  PMID: 36130397.
Vitkova M, Diouf I, Malpas C, Horakova D, Havrdova EK, Patti F, Ozakbas S, Izquierdo G, Eichau S, Shaygannejad V: Association of latitude and exposure to ultraviolet B radiation with severity of multiple sclerosis: an international registry study. Neurology 2022, 98:e2401-e2412.
Wang X, Carcel C, Hsu B, Shajahan S, Miller M, Peters S, Randall DA, Havard A, Redfern J, Anderson CS, Jorm L, Woodward M. Differences in the pre-hospital management of women and men with stroke by emergency medical services in New South Wales. Medical Journal of Australia 2022;217(3):143-148. doi: 10.5694/mja2.51652. PMID: 35831059.
Wang X, Di Tanna GL, Moullaali TJ, Martin RH, Shipes VB, Robinson TG, Chalmers J, Suarez JI, Qureshi AI, Palesch YY, Anderson CS. J-shape relation of blood pressure reduction and outcome in acute intracerebral hemorrhage: a pooled analysis of INTERACT2 and ATACH-II individual participant data. International Journal of Stroke 2022;17(10)1129-1136. PMID: 34983270.  DOI: 10.1177/17474930211064076.
Wang X, Wang H, Du X, Wang Z, Li C, Anderson CS, Zhang J, Hou X, Dong J. EvaLuation of early CRRT and beta-blocker InTervention in patients with ECMO (ELITE) trial: study protocol for a 2 × 2 partial factorial randomized controlled trial. Trials 2022;23(1):684. doi: 10.1186/s13063-022-06617-x. PMCID: PMC9389730.
Winkelmann A, Loebermann M, Barnett M, Hartung H-P, Zettl UK: Vaccination and immunotherapies in neuroimmunological diseases. Nature Reviews Neurology 2022, 18:289-306.
Wu S, Anderson CS. Precision management of brain oedema after acute ischaemic stroke. Precision Clinical Medicine 2022;5(3):pbac019. doi: 10.1093/pcmedi/pbac019. PMID: 35990896; PMCID: PMC9384835
Xiaoxi Z, Xuan Z, Lei Z, Zifu L, Pengfei X, Hongjian S, Yongxin Z, Weilong H, Yihan Z, Dongwei D, Qiang L, Rui Z, Qinghai H, Yi X, Song L, Anderson CS, Jianmin L, Yongwei Z, Pengfei Y. Baseline blood pressure does not modify the effect of intravenous thrombolysis in successfully revascularized patients. Front Neurol. 2022 Sep 12;13:984599. doi: 10.3389/fneur.2022.984599. PMID: 36172030; PMCID: PMC9510834
Xie, D., Welgampola, M., Miller, L., Young, A., D'Souza, M., Breen, N., Rosengren, S. (2022). Subjective Cognitive Dysfunction in Patients with Dizziness and Vertigo. Audiology and Neurotology, 27(2), 122-132.
Yang M, Cheng H, Wang X, Ouyang M, Shajahan S, Carcel C, Anderson CS, Kristoffersen ES, Sandset EC, Yang J. Antithrombotics prescription and adherence among stroke survivors: a systematic review and meta-analysis. Brain and Behaviour 2022;12(10):e2752.  PMID: 36067030 DOI: 10.1002/brb3.2752   
Yang P, Song L, Zhang Y, Zhang X, Chen X, Li Y, Sun L, Wan Y, Billot L, Li Q, Ren X, Shen H, Zhang L, Li Z, Xing P, Zhang Y, Zhang P, Hua W, Shen F, Zhou Y, Tian B, Chen W, Han H, Zhang L, Xu C, Li T, Peng Y, Yue X, Chen S, Wen C, Wan S, Yin C, Wei M, Shu H, Nan G, Liu S, Liu W, Cai Y, Sui Y, Chen M, Zhou Y, Zuo Q, Dai D, Zhao R, Li Q, Huang Q, Xu Y, Deng B, Wu T, Lu J, Wang X, Parsons MW, Butcher K, Campbell B, Robinson TG, Goyal M, Dippel D, Roos Y, Majoie C, Wang L, Wang Y, Liu J, Anderson CS; ENCHANTED2/MT Investigators. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial. Lancet 2022;400(10363):1585-1596. doi: 10.1016/S0140-6736(22)01882-7. Epub 2022 Oct 28. PMID: 36341753.
Yang Y, Eshraghian J, Truong ND, Nikpour A, Kavehei O. Neuromorphic Deep Spiking Neural Networks for Seizure Detection. 2022.
Yang Y, Truong ND, Eshraghian JK, Maher C, Nikpour A, Kavehei O. A multimodal AI system for out-of-distribution generalization of seizure identification. IEEE Journal of Biomedical and Health Informatics. 2022;26(7):3529-38.
Yang Y, Truong ND, Eshraghian JK, Nikpour A, Kavehei O. Weak self-supervised learning for seizure forecasting: a feasibility study. Royal Society Open Science. 2022;9(8):220374.
Young AS, Nham B, Bradshaw AP, Calic Z, Pogson JM, Gibson WP, Halmagyi GM, Welgampola MS. Clinical, oculographic and vestibular test characteristics of Ménière's disease. J Neurol. 2022 Apr;269(4):1927-1944. doi: 10.1007/s00415-021-10699-z. Epub 2021 Aug 22. PMID: 34420063.
Zeng R, Lv J, Wang H, Zhou L, Barnett M, Calamante F, Wang C: FOD-Net: A deep learning method for fiber orientation distribution angular super resolution. Medical Image Analysis 2022, 79:102431.
Zhao WY, Hua X, Ren X, Ouyang M, Chen C, Li Y, Yin X, Song P, Chen X, Wu S, Song L, Anderson CS. Increasing burden of stroke in China: a systematic review and meta-analysis of prevalence, incidence, mortality, and case fatality. International Journal of Stroke. 2022 Oct 22:17474930221135983. doi: 10.1177/17474930221135983. [Epub ahead of print]. PMID: 36274585
Zhao WY, Zhao WY, Zhang L, Wan Y, Chen X, Jin Y, Zhang L, Sum G, Katar A, Song L, Anderson CS. The association between functional status and physical pain with depressive symptoms after a stroke event: a cross-sectional analysis of the China Health and Retirement Longitudinal Study 2018. Frontiers Psychiatry 2022; 13:927856. doi: 10.3389/fpsyt.2022.927856. PMID: 36172512; PMCID: PMC9512144.
Zhong M, van der Walt A, Stankovich J, Kalincik T, Buzzard K, Skibina O, Boz C, Hodgkinson S, Slee M, Lechner-Scott J: Prediction of multiple sclerosis outcomes when switching to ocrelizumab. Multiple Sclerosis Journal 2022, 28:958-969.
Zhou Z, Xia C, Mair G, Delcourt C, Yoshimura S, Liu X, Chen Z, Malavera A, Carcel C, Chen X, Wang X, Al-Shahi Salman R, Robinson TG, Lindley RI, Chalmers J, Wardlaw JM, Parsons MW, Demchuck AM, Anderson CS. Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target. International Journal of Stroke 2022;17(5):566-575.  DOI: 10.1177/17474930211025436  PMID:  34096413.
Zhu C, Kalincik T, Horakova D, Zhen Z, Buzzard K, Skibina O, Alroughani R, Izquierdo G, Eichau S, Kuhle J: Efficacy and persistence between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation. Multiple Sclerosis Journal 2022, 28:645-647.
Zhu C, Zhou Z, Roos I, Merlo D, Kalincik T, Ozakbas S, Skibina O, Kuhle J, Hodgkinson S, Boz C: Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 2022, 93:1330-1337.